首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human ERBB3 Recombinant Antibody(Duligotuzumab)

Anti-Human ERBB3 Recombinant Antibody(Duligotuzumab)

产品编号

YR1277

别名

科研级 Duligotuzumab ( 度戈妥珠单抗 ), Anti-ERBB3 Recombinant Antibody, Research Grade Duligotuzumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Duligotuzumab ( 度戈妥珠单抗 ), Anti-ERBB3 Recombinant Antibody, Research Grade Duligotuzumab
Catalog NumberYR1277
Molecular NameDuligotuzumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundDuligotuzumab (INN) is a humanized IgG1 monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER3. It is in development by Roche. Clinical development for head and neck cancer and colorectal cancer have been discontinued, but phase I trials in combination with cobimetinib are evaluating safety for treatment of solid tumors.
CAS Number1314238-96-4
ApplicationFCM, IP, ELISA, Neut, FuncS, IF, WB
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetERBB3[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价